Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare cancer, and few studies have comprehensively investigated the immune microenvironment and rare lymphocyte-predominant (LP) cells. Here we develop a NLPHL specific lymphocyte-predominant ecotype (LPE) model to identify 34 distinct cell states across 14 cell types that co-occur within 3 LPEs for 171 cases. LPE1 and LPE2 were characterized by immunosuppressive microenvironments with high expression of B2M on LP cells, CD8 T-cell exhaustion, immune checkpoint genes expressed by follicular T-cells, and an improved freedom from progression compared to LPE3 in training (n = 109, with 65% LPE1/2) and validation cohorts (n = 62, with 61% LPE1/2). We validate the co-occurrence and co-localization of cell states using spatial transcriptomics. Protein expression of HLA-I and HLA-II on LP cells and SSTR2 on dendritic cells was predictive of LPE1 (C-statistic=0.69), LPE2 (C-statistic=0.79), and LPE3 (C-statistic=0.60). This study establishes a clinically relevant biologic categorization for NLPHL.

4th Department of Internal Medicine Hematology University Hospital and Faculty of Medicine Hradec Kralove Czechia

Department of Biomedical Data Science Stanford University Stanford CA USA

Department of Hemato oncology Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc Olomouc Czechia

Department of Hematology and Oncology Winship Cancer Institute of Emory University Atlanta GA USA

Department of Hematology Fakultni nemocnice Kralovske Vinohrady and 3rd Faculty of Medicine Charles University Prague Czechia

Department of Hematopathology MD Anderson Cancer Center Houston TX USA

Department of Infectious Diseases University of Rochester Rochester NY USA

Department of Lymphoma and Myeloma MD Anderson Cancer Center Houston TX USA

Department of Medicine Division of Oncology Stanford University Stanford CA USA

Department of Pathology at the Federal University of Rio de Janeiro Rio de Janeiro Brazil

Department of Pathology St Jude Children's Research Hospital Memphis TN USA

Department of Pathology Stanford University Stanford CA USA

Department of Pediatrics Division of Pediatric Hematology Oncology Stanford University Stanford CA USA

Department of Pediatrics University of Rochester Rochester NY USA

Department of Radiation Oncology MD Anderson Cancer Center Houston TX USA

Department of Radiation Oncology Stanford University Stanford CA USA

University College London Hospitals NHS Foundation Trust London UK

Zobrazit více v PubMed

Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. PubMed DOI PMC

Younes, S., Rojansky, R. B., Menke, J. R., Gratzinger, D. & Natkunam, Y. Pitfalls in the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: variant patterns, borderlines and mimics. PubMed DOI PMC

Campo, E. et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. PubMed PMC

Regula, D. P., Hoppe, R. T. & Weiss, L. M. Nodular and diffuse types of lymphocyte predominance Hodgkin’s disease. PubMed DOI

Eichenauer, D. A. et al. Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group. PubMed

Mauz-Körholz, C. et al. Pediatric nodular lymphocyte-predominant Hodgkin lymphoma: treatment recommendations of the GPOH-HD study group. PubMed DOI

Lukes, R. J. & Butler, J. J. The pathology and nomenclature of Hodgkin’s disease. PubMed

Fan, Z., Natkunam, Y., Bair, E., Tibshirani, R. & Warnke, R. A. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. PubMed DOI

Hartmann, S. et al. Tumor cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte predominant Hodgkin lymphoma. PubMed

Binkley, M. S. & Advani, R. H. Treatment approaches for nodular lymphocyte-predominant Hodgkin lymphoma. PubMed

Binkley, M. S. et al. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. PubMed DOI

Hartmann, S. et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). PubMed DOI

Binkley, M. S. et al. International prognostic score for nodular lymphocyte–predominant hodgkin lymphoma. PubMed DOI

Aoki, T. et al. Single cell transcriptome analysis reveals disease-defining T cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. PubMed

Ye, X. et al. A single-cell atlas of diffuse large B cell lymphoma. PubMed DOI

Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. PubMed DOI

Merkenschlager, J. et al. Dynamic regulation of TFH selection during the germinal centre reaction. PubMed DOI PMC

Suo, C. et al. Mapping the developing human immune system across organs. PubMed DOI PMC

Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. PubMed DOI PMC

Steen, C. B. et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. PubMed DOI PMC

Lo, A. C. et al. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW). PubMed

Stewart, B. J. et al. Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma. PubMed

Kurtz, D. M. et al. Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma. PubMed DOI PMC

Alig, S. K. et al. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. PubMed PMC

Younes, S. et al. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma. PubMed DOI PMC

Brune, V. et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. PubMed DOI PMC

Alaggio, R. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. PubMed DOI PMC

Natkunam, Y. et al.

Fan, J. et al. MuSiC2: cell-type deconvolution for multi-condition bulk RNA-seq data. PubMed DOI PMC

Tsoucas, D. et al. Accurate estimation of cell-type composition from gene expression data. PubMed DOI PMC

Schuhmacher, B. et al. JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. PubMed DOI PMC

Hartmann, S. et al. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. PubMed DOI

Foley, J. W. et al. Gene expression profiling of single cells from archival tissue with laser-capture microdissection and Smart-3SEQ. PubMed DOI PMC

Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. PubMed DOI PMC

Baume, D. M., Caligiuri, M. A., Manley, T. J., Daley, J. F. & Ritz, J. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. PubMed DOI

Tartey, S., Neale, G., Vogel, P., Malireddi, R. K. S. & Kanneganti, T.-D. A MyD88/IL1R axis regulates PD-1 expression on tumor-associated macrophages and sustains their immunosuppressive function in melanoma. PubMed DOI PMC

Griffioen, M. et al. Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. PubMed DOI PMC

Machy, P., Mortier, E. & Birklé, S. Biology of GD2 ganglioside: implications for cancer immunotherapy. PubMed PMC

Holmes, A. B. et al. Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome. PubMed DOI PMC

Miragaia, R. J. et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. PubMed DOI PMC

Luo, Y. et al. Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human Treg compartment. PubMed DOI PMC

Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. PubMed DOI

Roemer, M. G. M. et al. Classical Hodgkin lymphoma with reduced β2M/MHC class I expression is associated with inferior outcome independent of 9p24.1 status. PubMed DOI PMC

Boen, J., Wagner, J. P. & Di Nanni, N. DOI

Taylor, J. G., Truelove, E., Clear, A., Calaminici, M. & Gribben, J. G. PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion. PubMed DOI PMC

Advani, R. H. et al. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. PubMed DOI

Song, L. et al. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data. PubMed DOI PMC

Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. PubMed DOI PMC

Thurner, L. et al. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma. PubMed PMC

Zhang, X.-Y. & Collins, G. P. Checkpoint inhibitors and the changing face of the relapsed/refractory classical Hodgkin lymphoma pathway. PubMed PMC

Scherer, F. et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. PubMed DOI PMC

Riihijärvi, S. et al. Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial. PubMed DOI PMC

Paczkowska, J. et al. Single-cell RNA sequencing reveals the interplay between circulating CD4 + T cells, B cells and cancer-associated monocytes in classic Hodgkin lymphoma treated with PD-1 blockade. DOI

Binkley, M. S. et al. The prognostic impact of clinical factors and immunoarchitectural patterns for nodular lymphocyte-predominant Hodgkin lymphoma: an international study by glow. DOI

Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference. PubMed DOI PMC

Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. PubMed DOI PMC

Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. PubMed DOI PMC

Stuart, T. et al. Comprehensive integration of single-cell data. PubMed DOI PMC

Domínguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. PubMed DOI PMC

Luca, B. A. et al. Atlas of clinically distinct cell states and ecosystems across human solid tumors. PubMed DOI PMC

Moran, P. A. P. Notes on continuous stochastic phenomena. PubMed DOI